CGP 3466

Known as: CGP-3466 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
GAPDH (D-glyceraldehyde-3-phosphate dehydrogenase) is a multifunctional protein that is a target for the design of… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
Review
2004
Review
2004
Recent articles have highlighted numerous additional functions of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) that are… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
2003
2003
PURPOSE To analyze the effects of CGP 3466, a compound structurally related to deprenyl, on survival and function of fetal… (More)
Is this relevant?
Review
2002
Review
2002
Over the past several years, we have developed a number of novel aliphatic propargylamine-related compounds. These can be divided… (More)
Is this relevant?
2000
2000
The propargylamine derivative CGP 3466 (dibenzo[b,f]oxepin-10-ylmethyl-methyl-prop-2-ynyl-amine) has previously been found to… (More)
  • table 1
  • figure 9
Is this relevant?
2000
2000
(-)-Deprenyl, used for the treatment of Parkinson's disease, was reported to possess neurorescuing/antiapoptotic effects… (More)
Is this relevant?
1999
1999
In recent years, apoptotic cell death has been implicated with different progressive neurodegenerative diseases such as Parkinson… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
R-(-)-Deprenyl (Selegiline) represents one of the drugs currently used for the treatment of Parkinson's disease. This compound… (More)
Is this relevant?
1998
1998
Immobilized compounds for BIAcore studies and affinity precipitation as well as a fluorescent-labeled compound were prepared in… (More)
Is this relevant?